Therefore, the aim of this study is to investigate the relationship between decreased perioperative serum albumin level and AL in esophageal squamous cell cancer (ESCC) patients who underwent neoadjuvant therapy followed by minimally invasive esophagectomy (MIE) and to guide a patient-tailored optimization of treatment strategy. This evidence concerns the gene ALB and esophageal squamous cell carcinoma.